cache/f96d367c29100f040686fccd0dc0f206bf19fc91df813ff4044781e6c29b9682

COM:ISARNA-THERAPEUTICS

Isarna Therapeutics

  • Privately Held

Isarna Therapeutics is developing a portfolio of antisense therapies targeting TGF-β signaling pathways for therapeutic applications, including treatments for ophthalmology and fibrotic liver disease.

peer of